1,128
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Prediction of postoperative reintervention risk for uterine fibroids using clinical-imaging features and T2WI radiomics before high-intensity focused ultrasound ablation

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon & ORCID Icon
Article: 2226847 | Received 31 Mar 2023, Accepted 13 Jun 2023, Published online: 02 Jul 2023

References

  • Stewart EA, Cookson CL, Gandolfo RA, et al. Epidemiology of uterine fibroids: a systematic review. BJOG. 2017;124(10):1501–1512.
  • Baird DD, Dunson DB, Hill MC, et al. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):100–107.
  • De La Cruz MS, Buchanan EM. Uterine fibroids: diagnosis and treatment. Am Fam Physician. 2017;95(2):100–107.
  • Marinova M, Ghaei S, Recker F, et al. Efficacy of ultrasound-guided high-intensity focused ultrasound (USGHIFU) for uterine fibroids: an observational single-center study. Int J Hyperthermia. 2021;38(2):30–38.
  • Li F, Chen J, Yin L, et al. HIFU as an alternative modality for patients with uterine fibroids who require fertility-sparing treatment. Int J Hyperthermia. 2023;40(1):2155077.
  • Jolesz FA. MRI-guided focused ultrasound surgery. Annu Rev Med. 2009;60:417–430.
  • Ji Y, Hu K, Zhang Y, et al. High-intensity focused ultrasound (HIFU) treatment for uterine fibroids: a meta-analysis. Arch Gynecol Obstet. 2017;296(6):1181–1188.
  • Yan L, Huang H, Lin J, et al. High-intensity focused ultrasound treatment for symptomatic uterine fibroids: a systematic review and meta-analysis. Int J Hyperthermia. 2022;39(1):230–238.
  • Li W, Yang Z, Gao B, et al. Comparison of ultrasound-guided high-intensity focused ultrasound ablation and hysteroscopic myomectomy for submucosal fibroids: a retrospective study. Int J Hyperthermia. 2021;38(1):1609–1616.
  • Xu F, Deng L, Zhang L, et al. The comparison of myomectomy, UAE and MRgFUS in the treatment of uterine fibroids: a meta-analysis. Int J Hyperthermia. 2021;38(2):24–29.
  • Lambin P, Rios-Velazquez E, Leijenaar R, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer. 2012;48(4):441–446.
  • Mayerhoefer ME, Materka A, Langs G, et al. Introduction to radiomics. J Nucl Med. 2020;61(4):488–495.
  • Wang T, Gong J, Li Q, et al. A combined radiomics and clinical variables model for prediction of malignancy in T2 hyperintense uterine mesenchymal tumors on MRI. Eur Radiol. 2021;31(8):6125–6135.
  • Zheng Y, Chen L, Liu M, et al. Nonenhanced MRI-based radiomics model for preoperative prediction of nonperfused volume ratio for high-intensity focused ultrasound ablation of uterine leiomyomas. Int J Hyperthermia. 2021;38(1):1349–1358.
  • Keserci B, Duc NM, Nadarajan C, et al. Volumetric MRI-guided, high-intensity focused ultrasound ablation of uterine leiomyomas: ASEAN preliminary experience. Diagn Interv Radiol. 2020;26(3):207–215.
  • Qin S, Jiang Y, Wang F, et al. Development and validation of a combined model based on dual-sequence MRI radiomics for predicting the efficacy of high-intensity focused ultrasound ablation for hysteromyoma. Int J Hyperthermia. 2023;40(1):2149862.
  • Qin SZ, Jiang Y, Wang YL, et al. Predicting the efficacy of high-intensity focused ultrasound (HIFU) ablation for uterine leiomyomas based on DTI indicators and imaging features. Abdom Radiol. 2023.
  • Sandberg EM, Tummers F, Cohen SL, et al. Reintervention risk and quality of life outcomes after uterine-sparing interventions for fibroids: a systematic review and meta-analysis. Fertil Steril. 2018;109(4):698–707.e1.
  • Li W, Jiang Z, Deng X, et al. Long-term follow-up outcome and reintervention analysis of ultrasound-guided high intensity focused ultrasound treatment for uterine fibroids. Int J Hyperthermia. 2020;37(1):1046–1051.
  • Liu L, Wang T, Lei B. High-intensity focused ultrasound (HIFU) ablation versus surgical interventions for the treatment of symptomatic uterine fibroids: a meta-analysis. Eur Radiol. 2022;32(2):1195–1204.
  • Liu X, Tang J, Luo Y, et al. Comparison of high-intensity focused ultrasound ablation and secondary myomectomy for recurrent symptomatic uterine fibroids following myomectomy: a retrospective study. BJOG. 2020;127(11):1422–1428.
  • Wei C, Li N, Shi B, et al. The predictive value of conventional MRI combined with radiomics in the immediate ablation rate of HIFU treatment for uterine fibroids. Int J Hyperthermia. 2022;39(1):475–484.
  • Olaleye T, Abayomi-Alli A, Adesemowo K, et al. SCLAVOEM: hyper parameter optimization approach to predictive modelling of COVID-19 infodemic tweets using smote and classifier vote ensemble. Soft Comput. 2023;27(6):3531–3550.
  • Zhou Y, Zhang J, Chen J, et al. Prediction using T2-weighted magnetic resonance imaging-based radiomics of residual uterine myoma regrowth after high-intensity focused ultrasound ablation. Ultrasound Obstet Gynecol. 2022;60(5):681–692.
  • Huang X, Yu D, Zou M, et al. The effect of exercise on high-intensity focused ultrasound treatment efficacy in uterine fibroids and adenomyosis: a retrospective study. BJOG. 2017;124(Suppl 3):46–52.
  • Harmon QE, Patchel SA, Denslow S, et al. Vitamin D and uterine fibroid growth, incidence, and loss: a prospective ultrasound study. Fertil Steril. 2022;118(6):1127–1136.
  • Donnez J, Dolmans MM. Uterine fibroid management: from the present to the future. Hum Reprod Update. 2016;22(6):665–686.
  • Liu Y, Wu X, Wu A, et al. Ultrasound-guided high intensity focused ultrasound ablation for uterine fibroids: long-term outcomes and factors affecting local recurrence. Int J Hyperthermia. 2021;38(1):1341–1348.
  • Yang MJ, Yu RQ, Chen WZ, et al. A prediction of NPVR ≥ 80% of ultrasound-guided high-intensity focused ultrasound ablation for uterine fibroids. Front Surg. 2021;8:663128.
  • Zhao WP, Chen JY, Zhang L, et al. Feasibility of ultrasound-guided high intensity focused ultrasound ablating uterine fibroids with hyperintense on T2-weighted MR imaging. Eur J Radiol. 2013;82(1):e43–e49.
  • Wang YJ, Zhang PH, Zhang R, et al. Predictive value of quantitative uterine fibroid perfusion parameters from contrast-enhanced ultrasound for the therapeutic effect of high-intensity focused ultrasound ablation. J Ultrasound Med. 2019;38(6):1511–1517.
  • Yang F, Wang K, Sun L, et al. A hybrid sampling algorithm combining synthetic minority over-sampling technique and edited nearest neighbor for missed abortion diagnosis. BMC Med Inform Decis Mak. 2022;22(1):344.
  • Qian X, Zhou C, Wang F, et al. Development and validation of combined Ki67 status prediction model for intrahepatic cholangiocarcinoma based on clinicoradiological features and MRI radiomics. Radiol Med. 2023;128(3):274–288.
  • Nie F, Zhao X, Wang R, et al. Fast locality discriminant analysis with adaptive manifold embedding. IEEE Trans Pattern Anal Mach Intell. 2022;44(12):9315–9330.
  • Li Y, Eresen A, Lu Y, et al. Radiomics signature for the preoperative assessment of stage in advanced Colon cancer. Am J Cancer Res. 2019;9(7):1429–1438.
  • Ekert K, Hinterleitner C, Baumgartner K, et al. Extended texture analysis of non-enhanced whole-body MRI image data for response assessment in multiple myeloma patients undergoing systemic therapy. Cancers (Basel). 2020;12(3):761.
  • Zhao WP, Chen JY, Chen WZ. Effect of biological characteristics of different types of uterine fibroids, as assessed with T2-weighted magnetic resonance imaging, on ultrasound-guided high-intensity focused ultrasound ablation. Ultrasound Med Biol. 2015;41(2):423–431.
  • Zhao Y, Wang N, Wu J, et al. Radiomics analysis based on contrast-enhanced MRI for prediction of therapeutic response to transarterial chemoembolization in hepatocellular carcinoma. Front Oncol. 2021;11:582788.
  • Bortolotto C, Lancia A, Stelitano C, et al. Radiomics features as predictive and prognostic biomarkers in NSCLC. Expert Rev Anticancer Ther. 2021;21(3):257–266.